ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls

Jayesh Pandya, Magnus Hallström, Kerstin Andersson, Inger Nordström, Anna-Carin Lundell and Anna Rudin, Dept of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: CTLA-4, Early Rheumatoid Arthritis, T cells and T-Regulatory Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: T cell Biology and Targets in Autoimmune Disease Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: A comprehensive analysis of the circulating T cell subtype pattern, including T helper 1 (Th1) cells, Th2 cells, Th17 cells, Th1/Th17 cells, T follicular helper (Tfh)  cells, T follicular regulatory (Tfr) cells and T regulatory (Treg) cells in early untreated early RA compared to healthy controls has previously not been published.

Methods: Twenty-six patients with early RA satisfying the ACR 2010 criteria who had not received any DMARDS or prednisolone donated blood together with 18 sex and age matched healthy controls. Peripheral blood mononuclear cells were stained and analyzed by flow cytometry for combinations of chemokine receptors CCR4, CCR6 and CXCR3 to define Th1, Th2, Th17 and Th1/Th17 cells. Follicular T helper cells were defined using the expression of CXCR5 but lack of FOXP3, while follicular regulatory T cells were defined as expressing both CXCR5 and FOXP3. Regulatory T-cells were defined as expressing either CD25 and low CD127 or FOXP3. Analysis of mRNA expression for the respective transcription factors were performed on flow cytometry sorted cells and cytokine production from the cultured sorted T cells was analyzed to confirm that the chemokine receptor expression correctly defined the T cell subtypes. In addition, CTLA-4 was analyzed on both conventional and regulatory CD4+ T-cells. The disease activity of the patients was measured DAS28 and CDAI. The data was analyzed using multivariate factor analyses followed by univariate analyses.

Results: Multivariate discriminant analysis including all T cell subtypes showed that the best discriminators for early RA were the proportions of Th2 and Th17 cells that were found in higher proportions in early RA than in healthy controls and the Th1/Th17 cells that were found in lower fractions in early RA than in controls. Regulatory T cells were found in higher proportions in early RA than in controls, while the proportions of circulating follicular helper T cells did not differ between the groups. Principal component analysis of the T cells subtypes in the patients showed that Th2 cells clustered with the Th17 cells, Th1/Th17 cells clustered with the Th1 cells and Tfh cells clustered with the Tfreg cells, whereas Tregs and Th0 cells were positioned separately. Strong negative correlations were obtained between Th17 cells and the Th1 cells. The clinical inflammatory activity in untreated early RA was unrelated to any of the proportions of the circulating T cells subtypes except for the proportions of the CTLA-4 positive T cells that were positively related to higher clinical activity.

Conclusion: We found a dominance of circulating Th2 cells together with Th17 cells in early RA and the former should attract more attention in relation to pathogenesis of early stages of the disease.  Knowledge on what T cell subtypes dominate in the circulation in early rheumatoid arthritis may also guide us in developing new targeted treatments for this group.


Disclosure: J. Pandya, None; M. Hallström, None; K. Andersson, None; I. Nordström, None; A. C. Lundell, None; A. Rudin, None.

To cite this abstract in AMA style:

Pandya J, Hallström M, Andersson K, Nordström I, Lundell AC, Rudin A. Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/early-rheumatoid-arthritis-patients-have-higher-fractions-of-circulating-th2-cells-th17-cells-and-regulatory-t-cells-similar-fractions-of-follicular-helper-t-cells-and-lower-fractions-of-th17/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-rheumatoid-arthritis-patients-have-higher-fractions-of-circulating-th2-cells-th17-cells-and-regulatory-t-cells-similar-fractions-of-follicular-helper-t-cells-and-lower-fractions-of-th17/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology